3083 AZD9291 activity in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) and brain metastases: Data from Phase II studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

3083 AZD9291 activity in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) and brain metastases: Data from Phase II studies

Published:2015-09 Issue: Volume:51 Page:S625-S626
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ahn M.J.,Tsai C.M.,Yang J.C.H.,Shepherd F.A.,Satouchi M.,Kim D.W.,Bazhenova L.,Hirashima T.,Rukazenkov Y.,Cantarini M.,Mann H.,Ramalingam S.S.,Mitsudomi T.,Jänne P.A.,Goss G.D.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathology and treatment of primary and metastatic brain tumors;Neuropsychological and Psychosocial Foundations of Neuro-Oncology;2024

2. Overview of pathology and treatment of metastatic brain tumors;Handbook of Neuro-Oncology Neuroimaging;2022

3. Successful treatment of EGFR T790M-mutant non-small cell lung cancer with almonertinib after osimertinib-induced interstitial lung disease: a case report and literature review;Annals of Translational Medicine;2021-06

4. Mechanisms of EGFR Resistance in Glioblastoma;International Journal of Molecular Sciences;2020-11-11

5. Rapid effect of osimertinib re‑challenge on brain metastases developing during salvage cytotoxic chemotherapy after osimertinib treatment failure: A case report;Molecular and Clinical Oncology;2019-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP